Improving function of cytotoxic T‐lymphocytes by transforming growth factor‐β inhibitor in oral squamous cell carcinoma

Immunotherapy with immune‐checkpoint therapy has recently been used to treat oral squamous cell carcinomas (OSCCs). However, improvements in current immunotherapy are expected because response rates are limited. Transforming growth factor‐β (TGF‐β) creates an immunosuppressive tumor microenvironment...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondo, Yutaro, Suzuki, Susumu, Takahara, Taishi, Ono, Shoya, Goto, Mitsuo, Miyabe, Satoru, Sugita, Yoshihiko, Ogawa, Tetsuya, Ito, Hideaki, Satou, Akira, Tsuzuki, Toyonori, Yoshikawa, Kazuhiro, Ueda, Ryuzo, Nagao, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486191/
https://www.ncbi.nlm.nih.gov/pubmed/34309966
http://dx.doi.org/10.1111/cas.15081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486191/
https://www.ncbi.nlm.nih.gov/pubmed/34309966
http://dx.doi.org/10.1111/cas.15081

Ejemplares similares